172 related articles for article (PubMed ID: 19217532)
1. Clinical evaluation of antimicrobial peptide [(99m)Tc/Tricine/HYNIC(0)]ubiquicidin 29-41 as a human-specific infection imaging agent.
Gandomkar M; Najafi R; Shafiei M; Mazidi M; Goudarzi M; Mirfallah SH; Ebrahimi F; Heydarpor HR; Abdie N
Nucl Med Biol; 2009 Feb; 36(2):199-205. PubMed ID: 19217532
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial peptide 99mTc-ubiquicidin 29-41 as human infection-imaging agent: clinical trial.
Akhtar MS; Qaisar A; Irfanullah J; Iqbal J; Khan B; Jehangir M; Nadeem MA; Khan MA; Afzal MS; Ul-Haq I; Imran MB
J Nucl Med; 2005 Apr; 46(4):567-73. PubMed ID: 15809477
[TBL] [Abstract][Full Text] [Related]
3. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
Ortiz-Arzate Z; Santos-Cuevas CL; Ocampo-García BE; Ferro-Flores G; García-Becerra R; Estrada G; Gómez-Argumosa E; Izquierdo-Sánchez V
Nucl Med Commun; 2014 Apr; 35(4):423-32. PubMed ID: 24335877
[TBL] [Abstract][Full Text] [Related]
4. 99mTc-labeled antimicrobial peptide ubiquicidin (29-41) accumulates less in Escherichia coli infection than in Staphlococcus aureus infection.
Akhtar MS; Iqbal J; Khan MA; Irfanullah J; Jehangir M; Khan B; Ul-Haq I; Muhammad G; Nadeem MA; Afzal MS; Imran MB
J Nucl Med; 2004 May; 45(5):849-56. PubMed ID: 15136636
[TBL] [Abstract][Full Text] [Related]
5. Infection detection in mice using 99mTc-labeled HYNIC and N2S2 chelate conjugated to the antimicrobial peptide UBI 29-41.
Welling MM; Visentin R; Feitsma HI; Lupetti A; Pauwels EK; Nibbering PH
Nucl Med Biol; 2004 May; 31(4):503-9. PubMed ID: 15093821
[TBL] [Abstract][Full Text] [Related]
6. Clinical utility of 99mTc-ubiquicidin (29-41) as an adjunct to bone scan in differentiating infected versus noninfected loosening of prosthesis before revision surgery.
Shinto AS; Mukherjee A; Karuppusamy KK; Joseph J; Bhatt J; Korde A; Upadhya I; Arjun C; Samuel G; Dash A
Nucl Med Commun; 2017 Apr; 38(4):285-290. PubMed ID: 28244975
[TBL] [Abstract][Full Text] [Related]
7. [99mTc]HYNIC-RGD for imaging integrin alphavbeta3 expression.
Decristoforo C; Faintuch-Linkowski B; Rey A; von Guggenberg E; Rupprich M; Hernandez-Gonzales I; Rodrigo T; Haubner R
Nucl Med Biol; 2006 Nov; 33(8):945-52. PubMed ID: 17127166
[TBL] [Abstract][Full Text] [Related]
8. Utility of ⁹⁹mTc-labelled antimicrobial peptide ubiquicidin (29-41) in the diagnosis of diabetic foot infection.
Saeed S; Zafar J; Khan B; Akhtar A; Qurieshi S; Fatima S; Ahmad N; Irfanullah J
Eur J Nucl Med Mol Imaging; 2013 May; 40(5):737-43. PubMed ID: 23361858
[TBL] [Abstract][Full Text] [Related]
9. Biokinetics of (99m)Tc-UBI 29-41 in humans.
Meléndez-Alafort L; Rodríguez-Cortés J; Ferro-Flores G; Arteaga De Murphy C; Herrera-Rodríguez R; Mitsoura E; Martínez-Duncker C
Nucl Med Biol; 2004 Apr; 31(3):373-9. PubMed ID: 15028250
[TBL] [Abstract][Full Text] [Related]
10.
Ahmadpour S; Noaparast Z; Abedi SM; Hosseinimehr SJ
J Biomed Sci; 2018 Feb; 25(1):17. PubMed ID: 29455647
[TBL] [Abstract][Full Text] [Related]
11. Lys and Arg in UBI: a specific site for a stable Tc-99m complex?
Meléndez-Alafort L; Ramírez Fde M; Ferro-Flores G; Arteaga de Murphy C; Pedraza-López M; Hnatowich DJ
Nucl Med Biol; 2003 Aug; 30(6):605-15. PubMed ID: 12900286
[TBL] [Abstract][Full Text] [Related]
12. Role of 99mTc-ubiquicidin 29-41 scintigraphy to monitor antibiotic therapy in patients with orthopedic infection: a preliminary study.
Nazari B; Azizmohammadi Z; Rajaei M; Karami M; Javadi H; Assadi M; Asli IN
Nucl Med Commun; 2011 Aug; 32(8):745-51. PubMed ID: 21659909
[TBL] [Abstract][Full Text] [Related]
13. Clinical trial of specific imaging of infections.
Arteaga de Murphy C; Gemmel F; Balter J
Nucl Med Commun; 2010 Aug; 31(8):726-33. PubMed ID: 20526222
[TBL] [Abstract][Full Text] [Related]
14. Preliminary application of micro-SPECT/CT imaging by
Zhang Y; Meng L; Li B; Tan H; Lin QY; Cheng D; Shi H
Chem Biol Drug Des; 2019 Apr; 93(4):447-453. PubMed ID: 30381892
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of tricine and EDDA as Co-ligands for 99mTc-labeled HYNIC-MSH analogs for melanoma imaging.
Garcia MF; Zhang X; Gallazzi F; Fernandez M; Moreno M; Gambini JP; Porcal W; Cabral P; Quinn TP
Anticancer Agents Med Chem; 2015; 15(1):122-30. PubMed ID: 25175799
[TBL] [Abstract][Full Text] [Related]
16. [Comparative study of the biodistribution of (99m)Tc-HYNIC-Lys3-Bombesin obtained with the EDDA/tricine and NA/tricine as coligands].
Hernández-Cairo A; Perera-Pintado A; Prats-Capote A; Batista-Cuellar JF; Casacó-Santana C
Rev Esp Med Nucl Imagen Mol; 2012; 31(2):61-5. PubMed ID: 22305264
[TBL] [Abstract][Full Text] [Related]
17. (99m)tc-Ubiquicidin [29-41], a Promising Radiopharmaceutical to Differentiate Orthopedic Implant Infections from Sterile Inflammation.
Beiki D; Yousefi G; Fallahi B; Tahmasebi MN; Gholamrezanezhad A; Fard-Esfahani A; Erfani M; Eftekhari M
Iran J Pharm Res; 2013; 12(2):347-53. PubMed ID: 24250609
[TBL] [Abstract][Full Text] [Related]
18. Investigation of 99mTc-labelling of recombinant human interleukin-2 via hydrazinonicotinamide.
Karczmarczyk U; Garnuszek P; Maurin M; Di Gialleonardo V; Galli F; Signore A; Mikołajczak R
Nucl Med Biol; 2010 Oct; 37(7):795-803. PubMed ID: 20870154
[TBL] [Abstract][Full Text] [Related]
19. Studies on batch formulation of a kit for the preparation of the 99mTc-Ubiquicidin (29-41): An infection imaging agent.
Arjun C; Mukherjee A; Bhatt J; Chaudhari P; Repaka KM; Venkatesh M; Samuel G
Appl Radiat Isot; 2016 Jan; 107():8-12. PubMed ID: 26405838
[TBL] [Abstract][Full Text] [Related]
20. Tricine co-ligand improved the efficacy of
Shaghaghi Z; Abedi SM; Hosseinimehr SJ
Biomed Pharmacother; 2018 Aug; 104():325-331. PubMed ID: 29775901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
